Enteropathogenic Escherichia coli (EPEC): Does it have a role in colorectal tumourigenesis? A Prospective Cohort Study

International Journal of Surgery

Volumn 18, Issue , 2015, Pages 169-173

  Magdy, A ^a   Elhadidy, M ^a   Abd Ellatif, M E ^a   El Nakeeb, A ^a   Abdallah, E ^a   Thabet, W ^a   Youssef, M ^a   Khafagy, W ^a   Morshed, M ^a   Farid, M ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Colorectal cancer; Escherichia coli; PCR

Indexed keywords

AGGLUTINATION TEST; ARTICLE; BACTERIAL VIRULENCE; CANCER PATIENT; CARCINOGENESIS; COHORT ANALYSIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; DEMOGRAPHY; ENTEROPATHOGENIC ESCHERICHIA COLI; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROTYPING; ADULT; AGED; COLORECTAL TUMOR; GENETICS; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; POLYMERASE CHAIN REACTION; VIRULENCE; YOUNG ADULT;

ADULT; AGED; COLORECTAL NEOPLASMS; ENTEROPATHOGENIC ESCHERICHIA COLI; FEMALE; GENOTYPE; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; SEROTYPING; VIRULENCE; YOUNG ADULT;

EID: 84930442598     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2015.04.077     Document Type: Article

References (27)

1. Pisani P., Parkin D.M., Munoz N., Ferlay J. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol. Biomarkers Prev. 1997, 6:387-400. 56:1279-1282.
2. Mager D. Bacteria and cancer: cause, coincidence or cure? A review. J.Transl. Med. 2006, 4:14.
3. Kuper H., Adami H.O., Trichopoulos D. Infections as a major preventable cause of human cancer. J.Intern. Med. 2000, 248:171-183.
4. Martin H.M., Campbell B.J., Hart C.A., et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004, 127:80-93.
5. Swidsinski A., Khilkin M., Kerjaschki D., Schreiber S., Ortner M. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology 1998, 115:281-286.
6. Nataro J.P., Kaper J.B. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 1998, 11:142-201.
7. Blanco M., Blanco J.E., Mora A., et al. Serotypes, virulence genes and intimin types of Shiga toxin (Verotoxin)-producing Escherichia coli isolates from cattle in Spain: identification of a new intimin variant gene (eae-xi). J.Clin. Microbiol. 2004, 42:645-651.
8. Clarke S.C., Haigh R.D., Freestone P.P., Williams P.H. Virulence of enteropathogenic Escherichia coli, a global pathogen. Clin. Microbiol. Rev. 2003, 16:365-378.
9. Kenny B., Finlay B.B. Intimin-dependent binding of enteropathogenic Escherichia coli to host cells triggers novel signaling events, including tyrosine phosphorylation of phospholipase C-gamma1. Infect. Immun. 1997, 65:2528-2536.
10. Moon H.W., Whipp S.C., Argenzio R.A., Levine M.M., Giannella R.A. Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines. Infect. Immun. 1983, 41:1340-1351.
11. Hardwidge P.R., Rodriguez-Escudero I., Goode D., Donohoe S., Eng J. Proteomic analysis of the intestinal epithelial cell response to enteropathogenic Escherichia coli. J.Biol. Chem. 2004, 279:20127-20136.
12. Scaletsky I.C.A., Silva M.L.M., Trabulsi L.R. Distinctive patterns of adherence of enteropathogenic Escherichia coli to HeLa cells. Infect. Immun. 1984, 45:534-536.
13. Kaper J.B. Defining EPEC. Rev. Microbiol. 1996, 27:130-133.
14. Trabulsi L.R., Keller R., Tardelli Gomes T.A. Typical and atypical enteropathogenic Escherichia coli. Emerg. Infect. Dis. 2002, 8:508-513.
15. Forbes B.E., Sahm D.F., Weissfeld A.S., Trevino E.A. Bailey & Scott's Diagnostic Microbiology 2002, The C.V. Mosby Company, Toronto. 11th ed.
16. Beaudry M., Zhu C., Fairbrother J.M., Harel J. Genotypic and phenotypic characterization of Escherichia coli isolates from dogs manifesting attaching and effacing lesions. J.Clin. Microbiol. 1996, 34:144-148.
17. Gunzburg S.T., Tornieporth N.G., Riley L.W. Identification of enteropathogenic Escherichia coli by PCR-based detection of the bundle-forming pilus gene. J.Clin. Microbiol. 1995, 33:1375-1377.
18. Lin Z., Kurazono H., Yamasaki S., Takeda Y. Detection of various variant verotoxin genes in Escherichia coli by polymerase chain reaction. Microbiol. Immunol. 1993, 37:543-548.
19. von Elm E., Altman D.G., Egger M., et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007, 335(7624):806-808.
20. Hill M.J., Crowther J.S., Drasar B.S., Hawksworth G., Aries V., Williams R.E.O. Bacteria and etiology of cancer of large bowel. Lancet 1971, 690:96-100.
21. Kane M.F., Loda M., Gaida G.M., et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 1997, 57:808-811.
22. Vogelmann R., Amieva M.R. the role of bacterial pathogens in cancer. Curr. Opin. Microbiol. 2007, 10:76-81.
23. Lei X., Zhu Y., Tomkinson A., Sun L. Measurement of DNA mismatch repair activity in live cells. Nucleic Acids Res. 2004, 32:e100.
24. Francis C.A., Jerse A.E., Kaper J.B., Falkow S. Characterisation of interactions of enteropathogenic Escherichia coli O127:H6 with mammalian cells invitro. J.Infect. Dis. 1991, 164:693-703.
25. Rhodes J.M., Campbell B.J. Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol. Med. 2002, 8:10-16.
26. Greten F.R., Eckmann L., Greten T.F., et al. IKKb links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004, 118:285-296.
27. Hope M.E., Hold G.L., Kain R., El Omar E.M. Sporadic colorectal cancer - role of the commensal microbiota. FEMS Microbiol. Lett. 2005, 244:1-7.